Search results

• Tetrahydrocannabinol
  ...thways involving the μ₁ [[opioid receptor]], precipitating a [[dopamine]] release in the [[nucleus accumbens]]. The effects of the drug can be supp ...apsulated in Soft Gelatin Capsules From Schedule I to Schedule II" (DEA 51 FR 17476-78). This permitted medical use of Marinol, albeit with the severe re
  50 KB (6,686 words) - 22:09, 21 September 2010
• Neuromodulation
  ...aving an effect on multiple neurons. Examples of neuromodulators include [[dopamine]], [[serotonin]], [[acetylcholine]], [[histamine]] and others. ...ansmitter systems are the [[noradrenaline]] (norepinephrine) system, the [[dopamine]] system, the [[serotonin]] system and the [[cholinergic]] system. Drugs ta
  11 KB (1,374 words) - 22:11, 21 September 2010
• Neurochemistry
  ...2, ideas were more concrete. Neurochemicals such as [[norepinephrine]], [[dopamine]], and [[serotonin]] were classified as "putative neurotransmitters in cert [[fr:Neurochimie]]
  2 KB (288 words) - 22:11, 21 September 2010
• Signal transduction
  ...ef name=missale>{{cite journal|author =Missale C, Nash SR. ''et al''|title=Dopamine receptors:from structure to function|journal=Physiol. Rev.|year=1998|volume [[fr:Transduction de signaux]]
  55 KB (7,677 words) - 22:12, 21 September 2010
• Buprenorphine
  ...lesser degree than full agonists do. This slight release of serotonin and dopamine may contribute to the anti-depressant properties of buprenophine, especiall [[fr:Buprénorphine]]
  59 KB (8,561 words) - 22:13, 21 September 2010
• Phencyclidine
  ...html NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2receptorsimplications for models of schizophrenia](20 ...= August | pmid = 19391150 | doi = 10.1002/syn.20647}}</ref> as well as [[dopamine reuptake inhibitor]]s.{{Citation needed|date=April 2010}}
  21 KB (3,002 words) - 21:02, 24 September 2010
• Salvia divinorum
  | title = Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, | title=Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in
  133 KB (18,241 words) - 22:14, 21 September 2010
• Dextromethorphan
  [[Category:Dopamine reuptake inhibitors]] [[fr:Dextrométhorphane]]
  26 KB (3,444 words) - 22:15, 21 September 2010
• Gamma-Hydroxybutyric acid
  ...s=284–9 |year=2005 |month=March |pmid=15745703 |doi= |url=http://www.edk.fr/reserve/revues/ms_papier/e-docs/00/00/06/F7/document_article.md}}</ref> and ...oxone]] and [[naltrexone]]. Dynorphin may play a role in the inhibition of dopamine release via [[kappa opioid receptor]]s.<ref>{{cite journal |author=Mamelak
  55 KB (7,839 words) - 21:04, 24 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)